ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Isolauri, J.
Right arrow Articles by Autio, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Isolauri, J.
Right arrow Articles by Autio, V.

The Annals of Thoracic Surgery, Vol 43, 420-424, Copyright © 1987 by The Society of Thoracic Surgeons


ARTICLES

Colon interposition in the treatment of carcinoma of the esophagus and gastric cardia

J Isolauri, H Markkula and V Autio

The stomach is the organ most used for restoring esophageal continuity after esophageal resection for malignancy. In the present series, we report our experience over a 20-year period (1965 through 1984) with an alternative method, colon interposition. Two hundred forty-eight patients (124 men and 124 women) underwent colon interposition. Seventy- one percent (175) of the tumors were squamous cell carcinomas, and 23% (58) were adenocarcinomas in the gastric cardia and lower esophagus. The left colon was the substitute of first choice and was used in 54% of the patients. Of the interpositions, 59% were antiperistaltic. Esophagectomy without thoracotomy was the method in 146 patients. The operative mortality was 16% (40 patients), and 3% (8 patients) sustained colon graft necrosis. Leakage in the upper anastomosis occurred in 4% (10). No dysphagia was experienced by 85%, 80%, and 76% of the patients during reexaminations 3, 6, and 12 months, respectively, after operation. The 1-year and 5-year survival for patients with squamous cell carcinoma was 40% and 10%, respectively, and for patients with adenocarcinoma, 50% and 12%, respectively. The data from this study suggest that colon interposition offers a good alternative for long-term relief of dysphagia in patients with carcinoma of the esophagus. The rate of complications is acceptable.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
N. T. Nguyen, M. Hinojosa, C. Fayad, J. Gray, Z. Murrell, and M. Stamos
Laparoscopic and Thoracoscopic Ivor Lewis Esophagectomy With Colonic Interposition
Ann. Thorac. Surg., December 1, 2007; 84(6): 2120 - 2124.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
P. A. Davis, S. Law, and J. Wong
Colonic Interposition After Esophagectomy for Cancer
Arch Surg, March 1, 2003; 138(3): 303 - 308.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Davydov, I. Stilidi, and V. Bokhyan
Intrapleural colon interposition in gastric carcinoma patients
Eur. J. Cardiothorac. Surg., November 1, 2001; 20(5): 1063 - 1064.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. A. Mansour, F. C. Bryan, and G. W. Carlson
Bowel Interposition for Esophageal Replacement: Twenty-Five-Year Experience
Ann. Thorac. Surg., September 1, 1997; 64(3): 752 - 756.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1987 by The Society of Thoracic Surgeons.